Related Articles
Phosphodiesterase 4 inhibitor plus metformin is superior to metformin alone for the treatment of polycystic ovary syndrome: A rat model study
Effect of liraglutide on atherosclerosis in patients with impaired glucose tolerance: A double‑blind, randomized controlled clinical trial
Genetic polymorphisms of melatonin receptors 1A and 1B may result in disordered lipid metabolism in obese patients with polycystic ovary syndrome
Prepregnancy body mass indexes are associated with perinatal outcomes in females with preeclampsia
Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome?